—

Moderna Inc (MRNA) — Technical state

As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Signal: Uptrend stack intact — Trades +27.5% vs the 50-day and +168% vs the 200-day average, 10.7% below the 52-week high and +1025.8% off the 52-week low. Computed from daily closes. (as of 2026-11-10)
  • Trend: Moderna Inc trades 27.5% above its 50-day and 168.0% above its 200-day moving average. (as of 2026-11-10)

Moderna develops messenger RNA medicines, a technology that instructs cells to make a protein rather than delivering the protein itself. Its portfolio spans respiratory vaccines for COVID, RSV and influenza, vaccines against latent viruses and other pathogens, and early oncology and rare-disease programmes.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the MRNA overview. Research diary readings, not advice.

Uptrend stack intact

Trades +27.5% vs the 50-day and +168% vs the 200-day average, 10.7% below the 52-week high and +1025.8% off the 52-week low. Computed from daily closes.

The moving-average stack

FAQ · from the current data · as of 2026-11-10

Quick answers

What is the current Closelooknet signal on MRNA?

Uptrend stack intact — Trades +27.5% vs the 50-day and +168% vs the 200-day average, 10.7% below the 52-week high and +1025.8% off the 52-week low. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is MRNA above its 50-day and 200-day moving averages?

As of 2026-11-10, Moderna Inc trades +27.5% above its 50-day and +168% above its 200-day average, with the 20-day +9.4% away.

How far is MRNA from its 52-week high?

10.7% below the 52-week high and 1025.8% above the 52-week low, as of 2026-11-10.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.